Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant

Eli Lilly and Company

Identification number in the register: 04657143399-39
Registration date: 02/04/10 15:17:43

The information on this organisation was last modified on 27/11/14 09:53:19
The date of the last annual update was 06/03/14 11:06:47

Registrant : Organisation or self-employed individual

Name/company name: Eli Lilly and Company
Acronym: Lilly
Legal status: Corporation
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  John Lechleiter
Position: Chairman and CEO

Permanent person in charge of EU relations

Surname, Name: Mr  Kern Briggs
Position: Senior Director European Public Affairs

Contact details:

Contact details of organisation's head office: 1 Lilly Corporate Centre 
Indianapolis 46285
Telephone number: (+1) 3172762000
Fax number: (+) 
Other contact information: Lilly European Public Affairs
c/o Eli Lilly Benelux SA
Rue du Marquis 1
BE-1000 Brussels
+32 2 548 86 86
VAT BE 0406.754.454

Goals / remit

Goals / remit of the organisation: Lilly is a leading innovative biopharmaceutical company that unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Headquartered in the US, Lilly has over 39.000 employees worldwide with approximately 9.000 based in Europe. In 2013 global revenue was approx. $23 billion, of which over 23% were invested in R&D.


Elanco is the animal health branch of Lilly. Elanco is a global, innovation-driven company that develops and markets products to improve animal health and protein production in more than 75 countries. Elanco is committed to protein production, companion animal health and food safety and its products help the food industry produce an abundant supply of safe, nutritious and affordable food.

Both are part of Lilly as a single legal entity.
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 6
Complementary information: Note: Some are full-time engaged in the Brussels office and will spend approx 35% of time with EU affairs, whereas others may only spend a fraction of their time (5-10%).

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Athanasia Kanli 10/12/14 08/12/15


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

Clinical trials directive, transparency directive, TTIP, trade,intellectual property, EU 2020,Innovation Union, pharmaceuticals, healthcare,global health, innovation and research, veterinary medicine, business competitiveness, common agricultural policy,industrial policy.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Agriculture and Rural Development
  • Competition
  • Customs
  • Economic and Financial Affairs
  • Employment and Social Affairs
  • Enterprise
  • Environment
  • External Relations
  • General and Institutional Affairs
  • Internal Market
  • Public Health
  • Research and Technology
  • Taxation
  • Trade


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

Eli Lilly and Company is a member of the following associations: EFPIA, EuropaBio, AmChamEU, the British Chamber of Commerce to the EU, IFAH-Europe, FEFAC.

Note: All of those associations are registered within the EU transparency register.

Financial data

Financial year: 01/2013 - 12/2013
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 500000  € - 600000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

This estimate is calculated according to pro rate salary costs of Eli Lilly and Company staff involved in interest representation towards the European institutions, based on the proportion of employee time devoted to these activities. According to the Transparency Register Compliance guidelines on financial information, this estimate includes fees paid for outsourced activities (i.e consultancy contract fees). The estimate excludes membership fees to the various trade associations, as those organizations have registered themselves. The list is included in the “networks” section of this form.

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.

The organisation has also declared to be bound to the following other Code:
EFPIA Codes - and the Eli Lilly Code of Conduct ("The Red Book-Code of Business Conduct")